Article info
Clinical
Original article
HPTN 035 phase II/IIb randomised safety and effectiveness study of the vaginal microbicides BufferGel and 0.5% PRO 2000 for the prevention of sexually transmitted infections in women
- Correspondence to Dr M Bradford Guffey, Centre for Infectious Disease Research in Zambia, University of Alabama at Birmingham, 5032 Great North Road, P.O Box 34681, Lusaka 10101, Zambia; guffey{at}uab.edu
Citation
HPTN 035 phase II/IIb randomised safety and effectiveness study of the vaginal microbicides BufferGel and 0.5% PRO 2000 for the prevention of sexually transmitted infections in women
Publication history
- Received January 27, 2014
- Revised April 24, 2014
- Accepted May 10, 2014
- First published June 4, 2014.
Online issue publication
July 15, 2014
Article Versions
- Previous version (4 June 2014).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions